Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
Randomized, Blind, Placebo-controlled Study to Evaluate Safety and Efficacy of Ftortiazinon in Combination With Maxipime®, in Comparison With Placebo in Combination With Maxipime®, in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
Sponsor: Acellena Contract Drug Research and Development
A PHASE2 clinical study on Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa and Pseudomonas Aeruginosa, this trial is completed. The trial is conducted by Acellena Contract Drug Research and Development and has accumulated 12 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Jul 2025 — Sep 2025 [monthly]
Completed PHASE2
Status: Unknown → Completed
-
Sep 2024 — Jul 2025 [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Feb 2021 — Feb 2023 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Dec 2019 — Jan 2021 [monthly]
Recruiting PHASE2
-
Feb 2019 — Dec 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Acellena Contract Drug Research and Development
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
For direct contact, visit the study record on ClinicalTrials.gov .